Project Grant R21AG104539
- The National Institute on Aging awarded Visiting Nurse Service of New York $1,271,742 on September 15, 2025, under the Aging Research program (CFDA 93.866) to conduct a Stage II trial expanding the Virtual Caregiver Coach for You (ViCCY) intervention to caregivers of home health care patients with concurrent heart failure and cognitive impairment. The project enrolls 254 caregivers supporting patients with heart failure and cognitive impairment from home health care in New York City, plus at...
- The National Institute on Aging awarded the University of Rochester $188,445 on August 5, 2026, under the Aging Research program (CFDA 93.866) to conduct a randomized controlled trial evaluating dyadic life review therapy for distressed caregivers of older patients with Alzheimer's disease and related dementias and advanced cancer. The study will enroll 60 dyads of patients aged 65 and older with clinical impressions of AD/ADRD (including mild cognitive impairment) and stage III or IV cancer,...
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to study the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members. The $318,416 project will leverage natural experiments from the opening of new hospice facilities to estimate the effects of hospice utilization on patient outcomes such as pain management, depression, and activities of daily living. It will...
- The National Institute on Aging awarded New York University $3.053 million on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct longitudinal research on caregiving networks and their consequences among adults ages 85 and older. The award funds the ARIC CARES study, embedded within the Atherosclerosis Risk in Communities Study cohort. The research will characterize care ecosystems and relational coordination (teamwork) among family caregivers, paid caregivers, and...
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $713,283 on February 15, 2026, under the Aging Research program (CFDA 93.866) to assess readiness for palliative care integration in home healthcare, identify patients who would benefit from such services, and develop a home healthcare-specific screening tool. The recipient will measure palliative care-related knowledge, attitudes, and confidence among home healthcare clinicians and patients and...
- The National Institute on Aging, a component of the Department of Health and Human Services, awarded $834,775 to the Regents of the University of California, San Francisco on August 15, 2026, under the Aging Research program (CFDA 93.866) to conduct research identifying drivers of hospice disparities for older adults with and without Alzheimer's disease and related dementias (ADRD). The research examines regional hospice market variation as a structural factor driving disparities in hospice...
- The National Institute on Aging awarded The Trustees of Columbia University in the City of New York $734,346 on August 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a mixed-method, sequential explanatory study examining how private equity acquisition of hospice agencies affects end-of-life care and outcomes for people living with Alzheimer's disease and related disorders. The research quantifies associations between private equity acquisition and hospice use, quality, and...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded Weill Medical College of Cornell University $720,523 on June 15, 2026, under the Aging Research program (CFDA 93.866) to evaluate the impact of integrated dual-eligible special needs plans (D-SNPs) on utilization, quality, mortality, and chronic disease management among low-income individuals dually eligible for Medicare and Medicaid who qualify for Medicare based on disability. The study addresses a...
- The National Institute on Aging awarded Miami University $144,500 on June 15, 2026, under the Aging Research program (CFDA 93.866) to examine social factors that influence caregiver inclusion in older adult clinical appointments and identify which approaches to caregiver involvement produce optimal health outcomes. The project applies a person-centered analytic methodology to nationally representative data, conducting stage 0 activities under the NIH Stage Model to characterize social...
- The National Institute on Aging awarded The Research Foundation for The State University of New York (operating as Stony Brook University) $557,764 on September 1, 2026, under the Aging Research program (CFDA 93.866) to conduct a prospective cohort study examining cognitive and physical consequences of caregiving for individuals with Alzheimer's disease and related dementias. The Stony Brook Caregivers Research Study (SBCARES) will assess cognitive fluctuations in 120 older caregivers aged 60...
The National Institute on Aging, a component of the Department of Health and Human Services National Institutes of Health, awarded Weill Medical College of Cornell University $523,265 on September 1, 2026, under the Aging Research program (CFDA 93.866) to develop and pilot-test a single-session intervention aimed at improving the mental health of family caregivers of home hospice patients. The award funds adaptation and feasibility testing of a single-session intervention incorporating mindfulness and solution-focused therapy components. Approximately 2.3 million family caregivers of end-of-life patients experience significant mental health symptoms, with 33 percent of hospice caregivers experiencing moderate-to-severe anxiety and 23 percent experiencing moderate-to-severe depression, compared to 6 percent prevalence in the general population. Family hospice caregivers provide an average of 12.6 hours of caregiving daily. The project addresses an urgent need for feasible, acceptable mental health care delivery to this population. Work is performed at Weill Medical College of Cornell University in New York, New York. The period of performance runs from September 1, 2026, through August 31, 2028. Aim 1 involves adapting the intervention using expert feedback from hospice and mental health providers via a modified Delphi approach to develop a finalized protocol and manual. Aim 2 will determine feasibility and acceptability through a pilot randomized controlled trial with 1:1 allocation between the single-session intervention and usual care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $523.3k | 8/31/26 |